Skip to main content

Articles

Page 100 of 165

  1. Malaria in Cameroon is due to infections by Plasmodium falciparum and, to a lesser extent, Plasmodium malariae and Plasmodium ovale, but rarely Plasmodium vivax. A recent report suggested “Plasmodium vivax–like” ...

    Authors: Jerome Fru-Cho, Violet V Bumah, Innocent Safeukui, Theresa Nkuo-Akenji, Vincent PK Titanji and Kasturi Haldar
    Citation: Malaria Journal 2014 13:170
  2. Identifying human and malaria parasite movements is important for control planning across all transmission intensities. Imported infections can reintroduce infections into areas previously free of infection, m...

    Authors: Deepa K Pindolia, Andres J Garcia, Zhuojie Huang, Timothy Fik, David L Smith and Andrew J Tatem
    Citation: Malaria Journal 2014 13:169
  3. Plasmodium knowlesi is a simian parasite that has been recognized as the fifth species causing human malaria. Naturally-acquired P. knowlesi infection is widespread among human populations in Southeast Asia. The ...

    Authors: Ruhani Yusof, Yee Ling Lau, Rohela Mahmud, Mun Yik Fong, Jenarun Jelip, Hie Ung Ngian, Sahlawati Mustakim, Hani Mat Hussin, Noradilah Marzuki and Marlindawati Mohd Ali
    Citation: Malaria Journal 2014 13:168
  4. Despite the significant reduction of malaria transmission in Rwanda, Ruhuha sector is still a highly endemic area for malaria. The objective of this activity was to explore and brainstorm the potential roles o...

    Authors: Chantal Marie Ingabire, Jane Alaii, Emmanuel Hakizimana, Fredrick Kateera, Daniel Muhimuzi, Ingmar Nieuwold, Karsten Bezooijen, Stephen Rulisa, Nadine Kaligirwa, Claude Muvunyi, Constantianus JM Koenraadt, Leon Mutesa, Michele Van Vugt and Bart Van Den Borne
    Citation: Malaria Journal 2014 13:167
  5. In Zambia, there has been a large scaling up of interventions to control malaria in recent years including the deployment of rapid diagnostic tests (RDTs) to improve malaria surveillance data as well as guide ...

    Authors: Christine Manyando, Eric M Njunju, Justin Chileshe, Seter Siziya and Clive Shiff
    Citation: Malaria Journal 2014 13:166
  6. Although Colombia has witnessed an important decrease in malaria transmission, the disease remains a public health problem with an estimated ~10 million people currently living in areas with malaria risk and ~...

    Authors: David A Forero, Pablo E Chaparro, Andres F Vallejo, Yoldy Benavides, Juan B Gutiérrez, Myriam Arévalo-Herrera and Sócrates Herrera
    Citation: Malaria Journal 2014 13:165
  7. Malaria in highland areas of Kenya affects children and adults. Local clinicians include symptoms other than fever when screening for malaria because they believe that fever alone does not capture all cases of...

    Authors: Albino L Mutanda, Priscah Cheruiyot, James S Hodges, George Ayodo, Wilson Odero and Chandy C John
    Citation: Malaria Journal 2014 13:163
  8. The determinants and barriers for delivery and uptake of IPTp vary with different regions in sub-Saharan Africa. This study evaluated the determinants of ANC clinic attendance and IPTp-SP uptake among parturie...

    Authors: Judith K Anchang-Kimbi, Eric A Achidi, Tobias O Apinjoh, Regina N Mugri, Hanesh Fru Chi, Rolland B Tata, Blaise Nkegoum, Joseph-Marie N Mendimi, Eva Sverremark-Ekström and Marita Troye-Blomberg
    Citation: Malaria Journal 2014 13:162
  9. Malaria vector control strategies that target adult female mosquitoes are challenged by the emergence of insecticide resistance and behavioural resilience. Conventional larviciding is restricted by high operat...

    Authors: Dickson Lwetoijera, Caroline Harris, Samson Kiware, Stefan Dongus, Gregor J Devine, Philip J McCall and Silas Majambere
    Citation: Malaria Journal 2014 13:161
  10. Most odour baits for haematophagous arthropods contain carbon dioxide (CO2). The CO2 is sourced artificially from the fermentation of refined sugar (sucrose), dry ice, pressurized gas cylinders or propane. These ...

    Authors: Collins K Mweresa, Philemon Omusula, Bruno Otieno, Joop JA van Loon, Willem Takken and Wolfgang R Mukabana
    Citation: Malaria Journal 2014 13:160
  11. Before topical repellents can be employed as interventions against arthropod bites, their efficacy must be established. Currently, laboratory or field tests, using human volunteers, are the main methods used f...

    Authors: Onyango Sangoro, Dickson Lweitojera, Emmanuel Simfukwe, Hassan Ngonyani, Edgar Mbeyela, Daniel Lugiko, Japhet Kihonda, Marta Maia and Sarah Moore
    Citation: Malaria Journal 2014 13:159
  12. Microscopy and antigen detecting rapid diagnostic tests are the diagnostic tests of choice in management of clinical malaria. However, due to their limitations, the need to utilize more sensitive methods such ...

    Authors: Edwin Kamau, Saba Alemayehu, Karla C Feghali, Dennis W Juma, George M Blackstone, William R Marion, Peter Obare, Bernhards Ogutu and Christian F Ockenhouse
    Citation: Malaria Journal 2014 13:158
  13. Mexico is in the malaria pre-elimination phase; therefore, continuous assessment and understanding of the social and behavioural risk factors related to exposure to malaria are necessary to achieve the overall...

    Authors: Merit Mora-Ruiz, R Patricia Penilla, José G Ordóñez, Alma D López, Francisco Solis, José Luis Torres-Estrada and Américo D Rodríguez
    Citation: Malaria Journal 2014 13:157
  14. In the Western world, the diagnosis and management of Plasmodium vivax malaria in pregnant women can be challenging, and the pathogenesis of adverse outcomes for both the mother and the foetus is still poorly kno...

    Authors: Nicolò Binello, Enrico Brunetti, Federico Cattaneo, Raffaella Lissandrin and Antonello Malfitano
    Citation: Malaria Journal 2014 13:156
  15. Malaria has been shown to change blood counts. Recently, a few studies have investigated the alteration of the peripheral blood monocyte-to-lymphocyte count ratio (MLCR) and the neutrophil-to-lymphocyte count ...

    Authors: Nicole Berens-Riha, Inge Kroidl, Mirjam Schunk, Martin Alberer, Marcus Beissner, Michael Pritsch, Arne Kroidl, Günter Fröschl, Ingrid Hanus, Gisela Bretzel, Frank von Sonnenburg, Hans Dieter Nothdurft, Thomas Löscher and Karl-Heinz Herbinger
    Citation: Malaria Journal 2014 13:155
  16. The use of genetically modified mosquitoes (GMMs) for the control of malaria and other mosquito-borne diseases has been proposed in malaria-endemic countries, such as Nigeria, which has the largest burden in A...

    Authors: Patricia N Okorie, John M Marshall, Onoja M Akpa and Olusegun G Ademowo
    Citation: Malaria Journal 2014 13:154
  17. Malaria control interventions have been scaled-up in Zambia in conjunction with a malaria surveillance system. Although substantial progress has been achieved in reducing morbidity and mortality, national and ...

    Authors: Victor M Mukonka, Emmanuel Chanda, Ubydul Haque, Mulakwa Kamuliwo, Gabriel Mushinge, Jackson Chileshe, Kennedy A Chibwe, Douglas E Norris, Modest Mulenga, Mike Chaponda, Mbanga Muleba, Gregory E Glass and William J Moss
    Citation: Malaria Journal 2014 13:153
  18. In 2006, the first-line anti-malarial drug treatment in Tanzania was changed from sulphadoxine-pyrimethamine (SP) to artemether-lumefantrine (ALu), an artemisinin-based combination (ACT), since when the use of...

    Authors: Sungwa I Matondo, Godfrey S Temba, Adelaida A Kavishe, Julius S Kauki, Akili Kalinga, Marco van Zwetselaar, Hugh Reyburn and Reginald A Kavishe
    Citation: Malaria Journal 2014 13:152
  19. Antifolates are currently in clinical use for malaria preventive therapy and treatment. The drugs kill the parasites by targeting the enzymes in the de novo folate pathway. The use of antifolates has now been lim...

    Authors: Krittikorn Kümpornsin, Namfon Kotanan, Pornpimol Chobson, Theerarat Kochakarn, Piyaporn Jirawatcharadech, Peera Jaru-ampornpan, Yongyuth Yuthavong and Thanat Chookajorn
    Citation: Malaria Journal 2014 13:150
  20. Based on resistance of currently used anti-malarials, a new anti-malarial drug target against Plasmodium falciparum is urgently needed. Damaged DNA cannot be transcribed without prior DNA repair; therefore, uraci...

    Authors: Thidarat Suksangpleng, Ubolsree Leartsakulpanich, Saengduen Moonsom, Saranya Siribal, Usa Boonyuen, George E Wright and Porntip Chavalitshewinkoon-Petmitr
    Citation: Malaria Journal 2014 13:149
  21. Primaquine, the only available drug effective against Plasmodium falciparum sexual stages, induces also a dose-dependent haemolysis, especially in glucose-6-phosphate dehydrogenase deficient (G6PDd) individuals. ...

    Authors: Joseph Okebe, Alfred Amambua-Ngwa, Jason Parr, Sei Nishimura, Melissa Daswani, Ebako N Takem, Muna Affara, Serign J Ceesay, Davis Nwakanma and Umberto D’Alessandro
    Citation: Malaria Journal 2014 13:148
  22. The haemozoin crystal continues to be investigated extensively for its potential as a biomarker for malaria diagnostics. In order for haemozoin to be a valuable biomarker, it must be present in detectable quan...

    Authors: Charles Delahunt, Matthew P Horning, Benjamin K Wilson, Joshua L Proctor and Michael C Hegg
    Citation: Malaria Journal 2014 13:147
  23. Eliminating malaria from highly endemic settings will require unprecedented levels of vector control. To suppress mosquito populations, vector control products targeting their blood hosts must attain high biol...

    Authors: Gerry F Killeen, Aklilu Seyoum, John E Gimnig, Jennifer C Stevenson, Christopher J Drakeley and Nakul Chitnis
    Citation: Malaria Journal 2014 13:146
  24. The accuracy of the World Health Organization method of estimating malaria parasite density from thick blood smears by assuming a white blood cell (WBC) count of 8,000/μL has been questioned in several studies...

    Authors: Moses Laman, Brioni R Moore, John Benjamin, Nixon Padapu, Nandao Tarongka, Peter Siba, Inoni Betuela, Ivo Mueller, Leanne J Robinson and Timothy M E Davis
    Citation: Malaria Journal 2014 13:145
  25. Plasmodium vivax has the widest geographic distribution of the human malaria parasites and nearly 2.5 billion people live at risk of infection. The control of P. vivax in individuals and populations is complicate...

    Authors: Katherine E Battle, Markku S Karhunen, Samir Bhatt, Peter W Gething, Rosalind E Howes, Nick Golding, Thomas P Van Boeckel, Jane P Messina, G Dennis Shanks, David L Smith, J Kevin Baird and Simon I Hay
    Citation: Malaria Journal 2014 13:144
  26. Repositioning of existing drugs has been suggested as a fast track for developing new anti-malarial agents. The compound libraries of GlaxoSmithKline (GSK), Pfizer and AstraZeneca (AZ) comprising drugs that ha...

    Authors: Julie Lotharius, Francisco Javier Gamo-Benito, Iñigo Angulo-Barturen, Julie Clark, Michele Connelly, Santiago Ferrer-Bazaga, Tanya Parkinson, Pavithra Viswanath, Balachandra Bandodkar, Nikhil Rautela, Sowmya Bharath, Sandra Duffy, Vicky M Avery, Jörg J Möhrle, R Kiplin Guy and Timothy Wells
    Citation: Malaria Journal 2014 13:143
  27. Several species of Aspidosperma (Apocynaceae) are used as treatments for human diseases in the tropics. Aspidosperma olivaceum, which is used to treat fevers in some regions of Brazil, contains the monoterpenoid ...

    Authors: Talita PC Chierrito, Anna CC Aguiar, Isabel M de Andrade, Isabela P Ceravolo, Regina AC Gonçalves, Arildo JB de Oliveira and Antoniana U Krettli
    Citation: Malaria Journal 2014 13:142
  28. As anti-malarial drug resistance escalates, new safe and effective medications are necessary to prevent and treat malaria infections. The US Army is developing tafenoquine (TQ), an analogue of primaquine (PQ),...

    Authors: Qigui Li, Michael O’Neil, Lisa Xie, Diana Caridha, Qiang Zeng, Jing Zhang, Brandon Pybus, Mark Hickman and Victor Melendez
    Citation: Malaria Journal 2014 13:141
  29. Poor quality medicines threaten the lives of millions of patients and are alarmingly common in many parts of the world. Nevertheless, the global extent of the problem remains unknown. Accurate estimates of the...

    Authors: Patricia Tabernero, Facundo M Fernández, Michael Green, Philippe J Guerin and Paul N Newton
    Citation: Malaria Journal 2014 13:139
  30. Successful programmatic use of anti-malarials faces challenges that are not covered by standard drug development processes. The development of appropriate pragmatic dosing regimens for low-resource settings or...

    Authors: Eva Maria Hodel, Katherine Kay, Daniel J Hayes, Dianne J Terlouw and Ian M Hastings
    Citation: Malaria Journal 2014 13:138
  31. Monitoring mortality and morbidity attributable to malaria is paramount to achieve elimination of malaria. Diagnosis of malaria is challenging and PCR is a reliable method for identifying malaria with high sen...

    Authors: Gro EA Strøm, Sabrina Moyo, Maulidi Fataki, Nina Langeland and Bjørn Blomberg
    Citation: Malaria Journal 2014 13:137
  32. Long-lasting and sterile protective immunity against Plasmodium falciparum can be achieved by immunization of malaria-naive human volunteers under chloroquine prophylaxis with sporozoites delivered by mosquito bi...

    Authors: Marije C Behet, Lander Foquet, Geert-Jan van Gemert, Else M Bijker, Philip Meuleman, Geert Leroux-Roels, Cornelus C Hermsen, Anja Scholzen and Robert W Sauerwein
    Citation: Malaria Journal 2014 13:136
  33. Mutations in pfdhfr and pfdhps genes have been shown to associate with sulphadoxine-pyrimethamine (SP) resistance of Plasmodium falciparum parasites. However, pfdhfr, pfdhps genotypes and the correlations to SP t...

    Authors: Sukmawati Basuki, Fitriah, Sugeng Riyanto, Budiono, Yoes P Dachlan and Haruki Uemura
    Citation: Malaria Journal 2014 13:135
  34. Advanced oxidation protein products (AOPP) are newly identified efficient oxidative stress biomarkers. In a longitudinal birth cohort the effects were investigated of genetic polymorphisms in five oxidative pa...

    Authors: Guicheng Zhang, Oleksii A Skorokhod, Siew-Kim Khoo, Ruth Aguilar, Selma Wiertsema, Augusto J Nhabomba, Tiziana Marrocco, Michelle McNamara-Smith, Maria Nelia Manaca, Arnoldo Barbosa, Llorenç Quintó, Catherine M Hayden, Jack Goldblatt, Caterina Guinovart, Pedro L Alonso, Carlota Dobaño…
    Citation: Malaria Journal 2014 13:134
  35. In areas of high malaria transmission, Plasmodium falciparum infection during pregnancy is characterized by malaria-related anaemia, placental malaria and does not always result in clinical symptoms. This situati...

    Authors: Junior R Matangila, Jean Lufuluabo, Axel L Ibalanky, Raquel A Inocêncio da Luz, Pascal Lutumba and Jean-Pierre Van Geertruyden
    Citation: Malaria Journal 2014 13:132
  36. Current malaria vector control programmes rely on insecticides with rapid contact toxicity. However, spatial repellents can also be applied to reduce man-vector contact, which might ultimately impact malaria t...

    Authors: Sheila B Ogoma, Lena M Lorenz, Hassan Ngonyani, Robert Sangusangu, Mohammed Kitumbukile, Masoudi Kilalangongono, Emmanuel T Simfukwe, Anton Mseka, Edgar Mbeyela, Deogratius Roman, Jason Moore, Katharina Kreppel, Marta F Maia and Sarah J Moore
    Citation: Malaria Journal 2014 13:131
  37. Indonesia is among those countries committed to malaria eradication, with a continuously decreasing incidence of malaria. However, at district level the situation is different. This study presents a case of ma...

    Authors: E Elsa Herdiana Murhandarwati, Anis Fuad, Mubarika DF Nugraheni, Sulistyawati, Mahardika A Wijayanti, Barandi S Widartono and Ting-Wu Chuang
    Citation: Malaria Journal 2014 13:130
  38. Assessing the Plasmodium vivax burden in India is complicated by the potential threat of an emerging chloroquine (CQ) resistant parasite population from neighbouring countries in Southeast Asia. Chennai, the capi...

    Authors: Sneh Shalini, Saumyadripta Chaudhuri, Patrick L Sutton, Neelima Mishra, Nalini Srivastava, Joseph K David, K John Ravindran, Jane M Carlton and Alex Eapen
    Citation: Malaria Journal 2014 13:129
  39. Active, population-wide mass screening and treatment (MSAT) for chronic Plasmodium falciparum carriage to eliminate infectious reservoirs of malaria transmission have proven difficult to apply on large national s...

    Authors: Busiku Hamainza, Hawela Moonga, Chadwick H Sikaala, Mulakwa Kamuliwo, Adam Bennett, Thomas P Eisele, John Miller, Aklilu Seyoum and Gerry F Killeen
    Citation: Malaria Journal 2014 13:128
  40. Artemisinin-based combination therapy (ACT) plays an indispensable role in malaria control and elimination. However, the circulation of counterfeit, substandard drugs has greatly threatened malaria elimination...

    Authors: Lishan He, Tiegui Nan, Yongliang Cui, Suqin Guo, Wei Zhang, Rui Zhang, Guiyu Tan, Baomin Wang and Liwang Cui
    Citation: Malaria Journal 2014 13:127
  41. Malaria control is mainly based on indoor residual spraying and insecticide-treated bed nets. The efficacy of these tools depends on the behaviour of mosquitoes, which varies by species. With resistance to ins...

    Authors: Seynabou Sougoufara, Seynabou Mocote Diédhiou, Souleymane Doucouré, Nafissatou Diagne, Pape Mbacké Sembène, Myriam Harry, Jean-François Trape, Cheikh Sokhna and Mamadou Ousmane Ndiath
    Citation: Malaria Journal 2014 13:125
  42. The precise nature of the relationship between malaria mortality and levels of transmission is unclear. Due to methodological limitations, earlier efforts to assess the linkage have lead to inconclusive result...

    Authors: Susan F Rumisha, Thomas A Smith, Honorati Masanja, Salim Abdulla and Penelope Vounatsou
    Citation: Malaria Journal 2014 13:124
  43. Mosquitoes are the dominant vectors of pathogens that cause infectious diseases such as malaria, dengue, yellow fever and filariasis. Current vector control strategies often rely on the use of pyrethroids agai...

    Authors: David J Menger, Bruno Otieno, Marjolein de Rijk, W Richard Mukabana, Joop JA van Loon and Willem Takken
    Citation: Malaria Journal 2014 13:119
  44. Drug resistance in Plasmodium falciparum is a major problem in malaria control especially along the Thai-Myanmar and Thai-Cambodia borders. To date, a few molecular markers have been identified for anti-malarial ...

    Authors: Mathirut Mungthin, Somchai Intanakom, Nantana Suwandittakul, Preeyaporn Suida, Sakultip Amsakul, Naruemon Sitthichot, Suwich Thammapalo and Saovanee Leelayoova
    Citation: Malaria Journal 2014 13:117

Annual Journal Metrics

  • Citation Impact 2023
    Journal Impact Factor: 2.4
    5-year Journal Impact Factor: 2.6
    Source Normalized Impact per Paper (SNIP): 0.980
    SCImago Journal Rank (SJR): 1.105

    Speed 2023
    Submission to first editorial decision (median days): 7
    Submission to acceptance (median days): 131

    Usage 2023
    Downloads: 4,093,320
    Altmetric mentions: 5,053